Repression of peroxisome proliferation-activated receptor γ coactivator-1α by p53 after kidney injury promotes mitochondrial damage and maladaptive kidney repair

IF 12.6 1区 医学 Q1 UROLOGY & NEPHROLOGY Kidney international Pub Date : 2025-02-25 DOI:10.1016/j.kint.2025.02.009
Ying Wang , Yuqing Zeng , Ying Fu , Zhiwen Liu , Xiaoru Hu , Chengyuan Tang , Juan Cai , Zheng Dong
{"title":"Repression of peroxisome proliferation-activated receptor γ coactivator-1α by p53 after kidney injury promotes mitochondrial damage and maladaptive kidney repair","authors":"Ying Wang ,&nbsp;Yuqing Zeng ,&nbsp;Ying Fu ,&nbsp;Zhiwen Liu ,&nbsp;Xiaoru Hu ,&nbsp;Chengyuan Tang ,&nbsp;Juan Cai ,&nbsp;Zheng Dong","doi":"10.1016/j.kint.2025.02.009","DOIUrl":null,"url":null,"abstract":"<div><div>Maladaptive kidney repair after injury is associated with a loss of mitochondrial homeostasis, but the underlying mechanism is largely unknown. Moreover, it remains unclear whether this mitochondrial change contributes to maladaptive kidney repair or the development of chronic kidney problems after injury. Here, we report that the transcriptional coactivator peroxisome proliferation-activated receptor γ coactivator-1α (PGC1a), a master regulator of mitochondrial biogenesis, was persistently downregulated during maladaptive kidney repair after repeated low-dose cisplatin nephrotoxicity or unilateral ischemia/reperfusion injury. Administration of the PGC1α activator ZLN005 after either kidney injury not only preserved mitochondria but also attenuated kidney dysfunction, tubular damage, interstitial fibrosis, and inflammation. PGC1α downregulation in these models was associated with p53 activation. Notably, knockout of p53 from proximal tubules prevented PGC1α downregulation, attenuated chronic kidney pathologies and minimized functional decline. Inhibition of p53 with pifithrin-α, a cell permeable p53 inhibitor, had similar effects. Mechanistically, p53 bound to the PGC1α gene promoter during maladaptive kidney repair, and this binding was suppressed by pifithrin-α. Together, our results indicate that p53 is induced during maladaptive kidney repair to repress PGC1α transcriptionally, resulting in mitochondrial dysfunction for the development of chronic kidney problems. Activation of PGC1α and inhibition of p53 may improve kidney repair after injury and prevent the development of chronic kidney problems.</div></div>","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":"107 5","pages":"Pages 869-887"},"PeriodicalIF":12.6000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney international","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0085253825001619","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Maladaptive kidney repair after injury is associated with a loss of mitochondrial homeostasis, but the underlying mechanism is largely unknown. Moreover, it remains unclear whether this mitochondrial change contributes to maladaptive kidney repair or the development of chronic kidney problems after injury. Here, we report that the transcriptional coactivator peroxisome proliferation-activated receptor γ coactivator-1α (PGC1a), a master regulator of mitochondrial biogenesis, was persistently downregulated during maladaptive kidney repair after repeated low-dose cisplatin nephrotoxicity or unilateral ischemia/reperfusion injury. Administration of the PGC1α activator ZLN005 after either kidney injury not only preserved mitochondria but also attenuated kidney dysfunction, tubular damage, interstitial fibrosis, and inflammation. PGC1α downregulation in these models was associated with p53 activation. Notably, knockout of p53 from proximal tubules prevented PGC1α downregulation, attenuated chronic kidney pathologies and minimized functional decline. Inhibition of p53 with pifithrin-α, a cell permeable p53 inhibitor, had similar effects. Mechanistically, p53 bound to the PGC1α gene promoter during maladaptive kidney repair, and this binding was suppressed by pifithrin-α. Together, our results indicate that p53 is induced during maladaptive kidney repair to repress PGC1α transcriptionally, resulting in mitochondrial dysfunction for the development of chronic kidney problems. Activation of PGC1α and inhibition of p53 may improve kidney repair after injury and prevent the development of chronic kidney problems.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肾损伤后p53对过氧化物酶体增殖激活受体γ共激活因子-1α的抑制促进线粒体损伤和不适应肾修复。
损伤后肾脏修复不良与线粒体稳态的丧失有关,但其潜在机制在很大程度上尚不清楚。此外,目前尚不清楚这种线粒体变化是否会导致损伤后肾脏修复不良或慢性肾脏问题的发生。在这里,我们报道了转录共激活因子过氧化物酶体增殖激活受体γ共激活因子-1α (PGC1α),线粒体生物发生的主要调节因子,在重复低剂量顺铂肾毒性或单侧缺血/再灌注损伤后的不适应肾修复过程中持续下调。在肾损伤后给予PGC1α激活剂ZLN005不仅可以保存线粒体,还可以减轻肾功能障碍、肾小管损伤、间质纤维化和炎症。在这些模型中,PGC1α下调与p53激活有关。值得注意的是,从近端小管中敲除p53可防止PGC1α下调,减轻慢性肾脏病变并最大限度地减少功能下降。用聚氰菊酯-α(一种细胞渗透性p53抑制剂)抑制p53也有类似的效果。机制上,在不适应肾修复过程中,p53与PGC1α基因启动子结合,这种结合被聚氰菊酯-α抑制。总之,我们的研究结果表明,在不适应的肾脏修复过程中,p53被诱导抑制PGC1α的转录,导致线粒体功能障碍,导致慢性肾脏问题的发生。激活PGC1α和抑制p53可能改善损伤后肾脏的修复,防止慢性肾脏问题的发生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Kidney international
Kidney international 医学-泌尿学与肾脏学
CiteScore
23.30
自引率
3.10%
发文量
490
审稿时长
3-6 weeks
期刊介绍: Kidney International (KI), the official journal of the International Society of Nephrology, is led by Dr. Pierre Ronco (Paris, France) and stands as one of nephrology's most cited and esteemed publications worldwide. KI provides exceptional benefits for both readers and authors, featuring highly cited original articles, focused reviews, cutting-edge imaging techniques, and lively discussions on controversial topics. The journal is dedicated to kidney research, serving researchers, clinical investigators, and practicing nephrologists.
期刊最新文献
Kidney disease and heart failure: recent advances and current challenges: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Disease: Improving Global Outcomes (KDIGO): navigating a rapidly changing landscape. Intercalated cell subtype identity is controlled by reciprocal suppression of transcription factors. Editorial Board Table of Contents
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1